MUUD. Lozenges with phytocannabinoids
MUUD. pills with phytocannabinoids with a currant-raspberry flavor.
- Each lozenge contains 10 mg of phytocannabinoids
- The product does not contain sugars
- Increased bioavailability in an accelerated time
- 0,00% THC
- based on broad-spectrum extract
Technology used in MUUD. lozenges is the most effective way to deliver phytocannabinoids orally. Why?
MUUD. lozenges when placed in mouth dissolve slowly, thanks to which the released phytocannabinoids are directly absorbed into the bloodstream without being metabolized in the liver and intestine.
MUUD. lozenges increase the efficiency of phytocannabinoid absorption by:
- 200% higher bioavailability of phytocannabinoids
- 26 times higher concentration of CBD in the body just 5 minutes after consumption
- a constant and precise portion of phytocannabinoids enclosed in a tablet
MUUD. lozenges allow for long-term maintenance of the optimal content of phytocannabinoids in the body.
MUUD. lozenges is increased bioavailability in an accelerated time.
The properties of AdvanDropTM are confirmed by consumer opinions and laboratory tests carried out by independent research centers.
How to use?
MUUD. Dietary Supplement was created to make the consumption of phytocannabinoids easier and more enjoyable. It is an alternative for those who do not like or for whom it is difficult to use the existing forms of the extract.
Recommended portion for consumption during the day: from 1 to 4 tablets a day. It should be consumed at intervals of about 4 hours. Do not exceed the recommended daily intake. The dietary supplement cannot be used as a substitute for a balanced diet. The product is not intended for children, pregnant or lactating women. Excessive consumption may have a laxative effect.
Storage conditions: Store at room temperature in a dry place. The dietary supplement should be stored out of reach of small children.
Amount of active ingredients in a daily dose:
1 lozenge = 10 mg*
2 lozenge = 20 mg*
3 lozenge = 30 mg*
4 lozenge = 40 mg*
Sweeteners: isomalt and sucralose, AdvanDropTM (MCT oil, stabilizer E433, emulsifier: mono- and diglycerides of fatty acids, extract from the aerial part of hemp (Cannabis sativa L.)), acidity regulator: citric acid, natural flavors, dye: acid carmine.
AdvanDrop™ technology is currently the most effective way to deliver cannabinoids and vitamins A, D, E and K orally. It solves the current problem of their low bioavailability and short-term maintenance of the desired concentration in the body. This innovative solution is very important for consumers using CBD oils, other hemp-based products and vitamins A, D, E and K.
The CBD formula in the form of a liquid using the AdvanDrop® technology significantly improves the solubility of cannabinoids and terpenes in aqueous solutions, and thus accelerates and enhances the effects of CBD on the body through the endocannabinoid system (ECS). It is also convenient to use.
The AdvanDrop® technology enables lipophilic active compounds to dissolve in water, which increases their absorption in the body. This is confirmed by consumer opinions and pharmacokinetic tests performed by an independent laboratory in Finland, which show a 200% higher bioavailability of cannabinoids and (after just 5 minutes) 26 times higher blood concentration of CBD taken orally compared to CBD oils available on the market.
The high bioavailability of CBD delivered using the AdvanDrop® formula allows for long-term maintenance of the optimal concentration of cannabinoids in the body and supplementing its deficiencies in an easily measurable way.
The AdvanDrop® formula is covered by an international patent application. Its uniqueness lies in the fact that all preparations produced with the use of this technology ensure the same highest level of bioavailability as well as complete safety of use and technological advantage over other available forms of CBD supply.
- CBD content analysis certificates
Certificates of analysis confirming the CBD content and the rich cannabinoid background of the products separately for the ACTIVE, CALM and SLEEP functions.
- Security analysis reports
Reports on the laboratory analysis of the SLEEP, ACTIVE and CALM formulations in accordance with the TPD Directive, confirming the safety of MUUD. inhalers and the lack of overheating of the liquid based on CBD broad-spectrum distillate contained in the inhalers.
- Device test
Device test report in accordance with the TPD Directive, confirming the safety of MUUD. inhalers and the lack of overheating of the CBD broad-spectrum distillate liquid contained therein.
- Content marking
Test report on the determination of the content of CBD, CBDA, Δ9-THC and THCA in CBD oil separately for the ACTIVE, CALM and SLEEP functions, confirming the purity of THC (0.00%) of the substance used in MUUD. inhalers.
- Ecological certificates
Certificates confirming the ecological processes of cultivation and processing of hemp inflorescence, from which MUUD. CBD products are made.
- Excise stamp
MUUD inhalers are currently the only devices of this type on the market marked with the national excise mark of the Ministry of Finance of the Republic of Poland.